HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

5.300

+0.1302.51%

Volume:153.34M

Turnover:808.13M

Market Cap:99.43B

PE:25.31

High:5.350

Open:5.180

Low:5.110

Close:5.170

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Rallies 2.5% in Hong Kong, Outperforms Competitors

BRIEF-Sino Biopharmaceutical Says LM-108 Included In Breakthrough Therapy Designation

Sino Biopharmaceutical's LM-108 Monoclonal Antibody Enters Breakthrough Therapy Designation Process for Advanced Gastric Cancer Treatment in China

Sino Biopharmaceutical - Lm-108 Included in Breakthrough Therapy Designation Process by Center for Drug Evaluation of Nmpa

THOMSON REUTERS

Ludwig Enterprises Inc. Appoints Garth Lees-Rolfe as New Independent Director

Sino Biopharmaceutical Limited Presents Rovadicitinib Data at European Hematology Association Congress

Sino Biopharm's Graft-Versus-Host Disease Treatment Included in China's Breakthrough THerapy Designation Process

MT Newswires Live

Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment

BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension ("Rock2 Inhibitor") Included In Breakthrough Therapy Designation Process By CDE

Sino Biopharmaceutical - New Indication of Tdi01 Suspension ("Rock2 Inhibitor") Included in Breakthrough Therapy Designation Process by Cde

THOMSON REUTERS

Sino Biopharmaceutical Limited Secures FDA Approval for TQB3002 Clinical Trials, Showcasing Innovation-Driven Progress

Sino Biopharmaceutical Limited Conducted Annual General Meeting

BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 Injection

Sino Biopharmaceutical - Cde Approval to Initiate Phase Iii Registrational Clinical Study of Tqb2868 Injection Pd-1/Tgf- Bi-Functional Fusion Protein

THOMSON REUTERS

Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment

Sino Biopharmaceutical - Tqc3721 Inhalation Suspension "Pde3/4 Inhibitor" Approved by Center for Drug Evaluation by Nmpa China

THOMSON REUTERS

Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference

MT Newswires Live

Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference

MT Newswires Live

Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting

Sino Biopharm Presents Cancer Drug Data at Oncology Conference

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01177/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01177","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SINO BIOPHARM","latestPrice":5.3,"timestamp":1751011733025,"preClose":5.17,"halted":0,"volume":153337909,"delay":0,"floatShares":18761000000,"shares":18761000000,"eps":0.20942198438677465,"marketStatus":"Market Closed","change":0.13,"latestTime":"06-27 16:08:53","open":5.18,"high":5.35,"low":5.11,"amount":808126216,"amplitude":0.046422,"askPrice":5.31,"askSize":4704000,"bidPrice":5.3,"bidSize":481000,"shortable":3,"etf":0,"ttmEps":0.20935740033911074,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751247000000},"marketStatusCode":7,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":5.17,"dividendRate":0.013434,"openAndCloseTimeList":[[1750987800000,1750996800000],[1751000400000,1751011200000]],"volumeRatio":1.062806365181031,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.5226,"impliedVolPercentile":0.9146},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01177\",,,,,undefined,":{"symbol":"01177","floatShares":18761000000,"roa":"5.62%","roe":"11.82%","lyrEps":0.209422,"volumeRatio":1.062806365181031,"shares":18761000000,"dividePrice":0.071447,"high":5.35,"amplitude":0.046422,"preClose":5.17,"low":5.11,"week52Low":2.547,"pbRate":"2.84","psRate":"3.15","week52High":5.738,"institutionHeld":0,"latestPrice":5.3,"committee":-0.814465,"eps":0.20942198438677465,"divideRate":0.013481,"volume":153337909,"delay":0,"ttmEps":0.20935740033911074,"open":5.18,"prevYearClose":3.177,"prevWeekClose":4.99,"prevMonthClose":4.418,"prevQuarterClose":3.723,"fiveDayClose":4.99,"twentyDayClose":4.418,"sixtyDayClose":3.703},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01177\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546790511","title":"Sino Biopharmaceutical Stock Rallies 2.5% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2546790511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546790511?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:31","pubTimestamp":1751013060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.5% to 5.30 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 24284.15.Sino Biopharmaceutical Ltd. closed 8.3% below its 52-week high of HK$5.78, which the company achieved June 13.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 153.3 million shares, compared to the 50-day average of 132.7 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"2546985781","title":"BRIEF-Sino Biopharmaceutical Says LM-108 Included In Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2546985781","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546985781?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:32","pubTimestamp":1750933960,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says LM-108 Included In Breakthrough Therapy Designation June 26  - Sino Biopharmaceutical Ltd 1177.HK:LM-108 INCLUDED IN BREAKTHROUGH THERAPY DESIGNATION PROCESS BY CENTER FOR DRUG EVALUATION OF NMPAFurther company coverage: 1177.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nFWN3SS0UJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1191","BK1515","01177","BK1589","BK1521"],"gpt_icon":0},{"id":"2546331789","title":"Sino Biopharmaceutical's LM-108 Monoclonal Antibody Enters Breakthrough Therapy Designation Process for Advanced Gastric Cancer Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2546331789","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546331789?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:04","pubTimestamp":1750932248,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical's LM-108 Monoclonal Antibody Enters Breakthrough Therapy Designation Process for Advanced Gastric Cancer Treatment in China. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL8Q8D9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1191","BK1521","01177","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"2546786184","title":"Sino Biopharmaceutical -  Lm-108 Included in Breakthrough Therapy Designation Process by Center for Drug Evaluation of Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2546786184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546786184?lang=en_us&edition=fundamental","pubTime":"2025-06-26 17:57","pubTimestamp":1750931861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nFWN3SS0UJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","IE00BZ08YR35.GBP","BK1589","BK1515","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","01177","BK1521"],"gpt_icon":0},{"id":"2546240487","title":"Ludwig Enterprises Inc. Appoints Garth Lees-Rolfe as New Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2546240487","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546240487?lang=en_us&edition=fundamental","pubTime":"2025-06-26 01:41","pubTimestamp":1750873312,"startTime":"0","endTime":"0","summary":"Ludwig Enterprises Inc. has appointed Garth Lees-Rolfe as a new independent director, effective June 23, 2025. Lees-Rolfe brings over 19 years of experience in finance and strategic financial planning. He is currently the CFO of ABLi Therapeutics, Inc., and has held previous roles at Inhibikase Therapeutics, Inc. and F-Star, Inc. He has also worked at Ernst & Young and holds qualifications from the Queensland University of Technology and Kaplan Professional.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ludwig Enterprises Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 25, 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDLnSRwS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","01177","BK1191","BK1515","LUDG","BK1589","IE00BZ08YR35.GBP","BK4139","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2544752229","title":"Sino Biopharmaceutical Limited Presents Rovadicitinib Data at European Hematology Association Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2544752229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544752229?lang=en_us&edition=fundamental","pubTime":"2025-06-18 18:19","pubTimestamp":1750241961,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited is set to attend the 2025 European Hematology Association  Congress where they will present the preclinical and Phase Ib clinical data on rovadicitinib for the treatment of acute graft-versus-host disease . The results indicate an overall response rate of 84.6% at 28 days, with a 12-month overall survival rate of 92.3%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL9C8hlQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1521","IE00BZ08YS42.EUR","01177","BK1589","IE00BZ08YR35.GBP","BK1515","BK1191"],"gpt_icon":0},{"id":"2544961155","title":"Sino Biopharm's Graft-Versus-Host Disease Treatment Included in China's Breakthrough THerapy Designation Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2544961155","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544961155?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:21","pubTimestamp":1750159307,"startTime":"0","endTime":"0","summary":"China's medical products administrator included Sino Biopharmaceutical's  graft-versus-host disease treatment in the breakthrough therapy designation process, according to a Monday filing with the Hong Kong bourse.The TDI01 suspension is used to treat patients with moderate to severe chronic graft-versus-host disease who have received at least one prior treatment but not more than five lines of therapy.The drug showed safety and efficacy in phase 1B/2 trial participants, the filing said.Chronic graft-versus-host disease is among the major complications following stem cell treatment, occurring in about 30% to 70% of cases, the drug company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YT58.USD","BK4218","01177","BK4588","BK4181","BK1521","IE00BZ08YR35.GBP","BK1589","IE00BZ08YS42.EUR","BK1515","HST","BK1191","BK4585"],"gpt_icon":1},{"id":"2543675715","title":"Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675715?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:15","pubTimestamp":1750068924,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited's TDI01 Suspension Recognized in Breakthrough Therapy Designation Process by CDE for Chronic Graft-Versus-Host Disease Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL5v9DWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1521","01177","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589","BK1191"],"gpt_icon":1},{"id":"2543367579","title":"BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension (\"Rock2 Inhibitor\") Included In Breakthrough Therapy Designation Process By CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=2543367579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543367579?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:11","pubTimestamp":1750068708,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says New Indication Of TDI01 Suspension  Included In Breakthrough Therapy Designation Process By CDEJune 16  - Sino Biopharmaceutical Ltd 1177.HK:NEW INDICATION OF TDI01 SUSPENSION  INCLUDED IN BREAKTHROUGH THERAPY DESIGNATION PROCESS BY CDEFurther company coverage: 1177.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515","BK1521","IE00BZ08YR35.GBP","BK1191","01177"],"gpt_icon":0},{"id":"2543675491","title":"Sino Biopharmaceutical -  New Indication of Tdi01 Suspension (\"Rock2 Inhibitor\") Included in Breakthrough Therapy Designation Process by Cde","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675491?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:10","pubTimestamp":1750068611,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","IE00BZ08YS42.EUR","BK1515","01177","BK1191","IE00BZ08YT58.USD","BK1521","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2543528646","title":"Sino Biopharmaceutical Limited Secures FDA Approval for TQB3002 Clinical Trials, Showcasing Innovation-Driven Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2543528646","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543528646?lang=en_us&edition=fundamental","pubTime":"2025-06-13 06:11","pubTimestamp":1749766290,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited has announced significant progress in its innovation-driven development strategy, as highlighted in a recent voluntary announcement. The company's application for clinical trials of TQB6411, an EGFR/cMet Bispecific ADC, has been accepted by the Center for Drug Evaluation  of the National Medical Products Administration of China. Additionally, TQB2922, an EGFR/cMet Bispecific Antibody, has entered Phase I trials, while TQB3002, a Fourth-Generation EGFR Inhibitor, received approval for clinical trials from the United States Food and Drug Administration  in November of the previous year. These advancements underscore the company's commitment to innovation and its ongoing efforts to enhance its pipeline of clinical-stage assets with First-In-Class and Best-In-Class potential.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL4QbwH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","BK1515","BK1521","01177","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2542315952","title":"Sino Biopharmaceutical Limited Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542315952","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542315952?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:45","pubTimestamp":1749552308,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited held its Annual General Meeting on 10 June 2025. During the meeting, the proposal to receive and adopt the audited consolidated financial statements for the year ended 31 December 2024 was approved. Additionally, the proposal to approve the payment of a final dividend for the year ended 31 December 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDLH7tgL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1521","BK1191","BK1589","01177","BK1515"],"gpt_icon":0},{"id":"2542313294","title":"BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313294","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542313294?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:28","pubTimestamp":1749551300,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Updates On Phase III Registrational Clinical Study Of TQB2868 InjectionJune 10  - Sino Biopharmaceutical Ltd 1177.HK:CDE APPROVAL TO INITIATE PHASE III REGISTRATIONAL CLINICAL STUDY OF TQB2868 INJECTION PD-1/TGF- BI-FUNCTIONAL FUSION PROTEINFurther company coverage: 1177.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SC0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1191","BK1521","01177","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"2542390955","title":"Sino Biopharmaceutical - Cde Approval to Initiate Phase Iii Registrational Clinical Study of Tqb2868 Injection Pd-1/Tgf- Bi-Functional Fusion Protein","url":"https://stock-news.laohu8.com/highlight/detail?id=2542390955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542390955?lang=en_us&edition=fundamental","pubTime":"2025-06-10 17:57","pubTimestamp":1749549473,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SC0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YT58.USD","BK1589","BK1515","01177","BK1191","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521"],"gpt_icon":0},{"id":"2542338138","title":"Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338138","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542338138?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:41","pubTimestamp":1749469312,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited's TQC3721 Inhalation Suspension Receives Phase III Clinical Study Approval from CDE for COPD Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL4jQqDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE00BZ08YR35.GBP","BK1515","BK1589","BK1521","IE00BZ08YS42.EUR","01177","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2542882381","title":"Sino Biopharmaceutical - Tqc3721 Inhalation Suspension \"Pde3/4 Inhibitor\" Approved by Center for Drug Evaluation by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2542882381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542882381?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:39","pubTimestamp":1749469155,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SA01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1191","01177","IE00BZ08YS42.EUR","BK1515"],"gpt_icon":0},{"id":"2541446500","title":"Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2541446500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541446500?lang=en_us&edition=fundamental","pubTime":"2025-06-05 16:08","pubTimestamp":1749110917,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) presented the latest results of the phase III clinical study of its benmelstobart injection at the 2025 American Society of Clinical Oncology Annual Meeting, a Thursd","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1191","BK1521","01177","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2540779995","title":"Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2540779995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540779995?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:59","pubTimestamp":1748951972,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented the latest results of the phase III clinical study for benmelstobart injection in combination with anlotinib hydrochloride capsules at the American Society of Clinical Oncology's annual meetingThe drug is being tested as first-line treatment for non-small cell lung cancer in comparison with the pembrolizumab injection.The study has achieved the primary study endpoint of progression-free survival, in which the median survival was prolonged by more than 6 months in the population with TPS ≥50%.There was also a 40% reduction in the risk of disease progression and death as compared with the arm of pembrolizumab.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","AFG","01177","BK1521","BK1191","BK4107","BK1515","BK1589","BK4117","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2539250463","title":"Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539250463","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539250463?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:23","pubTimestamp":1748521386,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDLbJ1hqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1191","BK1589","BK1515","BK1521","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","01177"],"gpt_icon":0},{"id":"2538445804","title":"Sino Biopharm Presents Cancer Drug Data at Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2538445804","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538445804?lang=en_us&edition=fundamental","pubTime":"2025-05-28 15:13","pubTimestamp":1748416438,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  presented preliminary data from its first-in-human Phase I clinical study of cancer drug TQB2102 at the 2025 ASCO Annual Meeting, according to a Tuesday filing with the Hong Kong Exchange.The company reported encouraging results, with response rates of up to 70% in certain HER2-positive cancers, including breast and gastric cancers -- even among patients who had not responded to prior treatments.Side effects were described as manageable, with only a few cases of serious lung-related adverse events.TQB2102 is currently in Phase 3 trials and, if successful, could become the world's first approved bispecific HER2 antibody-drug conjugate , the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC","BK1521","IE00BZ08YT58.USD","BK1191","BK1515","IE00BZ08YS42.EUR","BK4231","ADC.AU","BK1589","BK4080","BK7095","IE00BZ08YR35.GBP","01177"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01177\",params:#limit:5,,,undefined,":[{"date":"2025-06-16","symbol":"01177","amount":0.04,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-17","defaultRemindTime":1750037400000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-10","payableDate":"2025-06-17","currency":"HKD","dateTimestamp":1750003200000,"payDate":"2025-07-10"},{"date":"2025-03-20","symbol":"01177","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742434200000,"name":null,"time":"Post Market","dateTimestamp":1742400000000,"actualEps":null},{"date":"2024-09-10","symbol":"01177","amount":0.03,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-09-11","defaultRemindTime":1725931800000,"name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-04","payableDate":"2024-09-11","currency":"HKD","dateTimestamp":1725897600000,"payDate":"2024-10-04"},{"date":"2024-08-13","symbol":"01177","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723512600000,"name":null,"time":"","dateTimestamp":1723478400000,"actualEps":null},{"date":"2024-06-11","symbol":"01177","amount":0.03,"announcedDate":"2024-03-28","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-12","name":"中国生物制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-12","currency":"HKD","dateTimestamp":1718035200000,"payDate":"2024-07-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01177\",market:\"HK\",,,undefined,":[{"executeDate":"2015-09-10","recordDate":"2015-09-11","paymentDate":"2015-09-25","value":0.015,"currency":"HKD"},{"executeDate":"2015-12-03","recordDate":"2015-12-04","paymentDate":"2015-12-18","value":0.01,"currency":"HKD"},{"executeDate":"2016-06-17","recordDate":"2016-06-20","paymentDate":"2016-07-06","value":0.015,"currency":"HKD"},{"executeDate":"2016-06-28","recordDate":"2016-06-29","paymentDate":"2016-07-13","value":0.015,"currency":"HKD"},{"executeDate":"2016-09-12","recordDate":"2016-09-13","paymentDate":"2016-09-29","value":0.015,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01177\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.619,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.619,"analysts":21,"updateTime":1742918400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01177\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01177","date":"2025-06-27","current":24.730575,"percent":0.608273,"low":4.081901,"twenty":8.758254,"median":20.194879,"eighty":33.775233,"high":66.468376,"avg":23.262146,"sd":16.203324,"marketCap":94788702171},"quantilePoints":[{"date":"2020-07-03","current":61.156807,"twenty":13.668949,"median":41.895696,"eighty":50.575171,"marketCap":186507158360},{"date":"2020-07-10","current":61.881891,"twenty":13.678843,"median":43.327138,"eighty":53.956,"marketCap":190518059129},{"date":"2020-07-17","current":61.53984,"twenty":13.701963,"median":44.431183,"eighty":56.233641,"marketCap":189766014059},{"date":"2020-07-24","current":60.843107,"twenty":13.716603,"median":45.405377,"eighty":56.910966,"marketCap":186883199696},{"date":"2020-07-31","current":61.461695,"twenty":13.759986,"median":45.958823,"eighty":58.777439,"marketCap":189891379973},{"date":"2020-08-07","current":58.963955,"twenty":13.769121,"median":46.360295,"eighty":59.883242,"marketCap":182370929281},{"date":"2020-08-14","current":55.542111,"twenty":13.795226,"median":46.520262,"eighty":59.435529,"marketCap":172218320846},{"date":"2020-08-21","current":55.411971,"twenty":13.832409,"median":46.795246,"eighty":59.213993,"marketCap":172594343381},{"date":"2020-08-28","current":60.163247,"twenty":13.843189,"median":47.558626,"eighty":59.213993,"marketCap":173722410985},{"date":"2020-09-04","current":58.986741,"twenty":13.850757,"median":47.865151,"eighty":59.435529,"marketCap":170902241975},{"date":"2020-09-11","current":57.173399,"twenty":13.883621,"median":48.442377,"eighty":59.21855,"marketCap":165825937758},{"date":"2020-09-18","current":57.33064,"twenty":13.942776,"median":49.171229,"eighty":58.982184,"marketCap":167894061698},{"date":"2020-09-25","current":55.524771,"twenty":13.951913,"median":49.248862,"eighty":58.955787,"marketCap":161313667343},{"date":"2020-09-30","current":54.359485,"twenty":13.954627,"median":49.670791,"eighty":58.931282,"marketCap":158681509601},{"date":"2020-10-09","current":53.778431,"twenty":13.960541,"median":49.956226,"eighty":58.340413,"marketCap":159245543403},{"date":"2020-10-16","current":50.497525,"twenty":13.997021,"median":50.336386,"eighty":58.143055,"marketCap":149468957503},{"date":"2020-10-23","current":50.355948,"twenty":14.012019,"median":50.497525,"eighty":58.116139,"marketCap":149280946236},{"date":"2020-10-30","current":49.587245,"twenty":14.022766,"median":50.497525,"eighty":57.977657,"marketCap":147024811028},{"date":"2020-11-06","current":50.89449,"twenty":14.085895,"median":50.432692,"eighty":57.866732,"marketCap":152665149047},{"date":"2020-11-13","current":49.724519,"twenty":14.135565,"median":50.355948,"eighty":57.69443,"marketCap":149280946236},{"date":"2020-11-20","current":49.012194,"twenty":14.18623,"median":50.176763,"eighty":57.578882,"marketCap":148065189992},{"date":"2020-11-27","current":47.319039,"twenty":14.216673,"median":50.039264,"eighty":57.517846,"marketCap":142616090360},{"date":"2020-12-04","current":46.016259,"twenty":14.236727,"median":49.897365,"eighty":57.391022,"marketCap":125705091503},{"date":"2020-12-11","current":46.402423,"twenty":14.271192,"median":49.828846,"eighty":57.304037,"marketCap":126456691452},{"date":"2020-12-18","current":53.761713,"twenty":14.294685,"median":49.832685,"eighty":57.21856,"marketCap":146749890081},{"date":"2020-12-24","current":51.299504,"twenty":14.315124,"median":49.897365,"eighty":57.170065,"marketCap":140173390525},{"date":"2020-12-31","current":51.553444,"twenty":14.337629,"median":50.061376,"eighty":57.163601,"marketCap":140924990475},{"date":"2021-01-08","current":51.570185,"twenty":51.495824,"median":51.669892,"eighty":52.08865,"marketCap":142240290386},{"date":"2021-01-15","current":48.164183,"twenty":49.466567,"median":51.481419,"eighty":51.825064,"marketCap":132657391033},{"date":"2021-01-22","current":54.463456,"twenty":49.466567,"median":51.553444,"eighty":52.465676,"marketCap":149944189865},{"date":"2021-01-29","current":48.94011,"twenty":49.115564,"median":51.481419,"eighty":52.465676,"marketCap":135851690817},{"date":"2021-02-05","current":50.665081,"twenty":49.478407,"median":51.553444,"eighty":52.234143,"marketCap":139797590551},{"date":"2021-02-11","current":51.544559,"twenty":49.814781,"median":51.450982,"eighty":52.040567,"marketCap":142428190373},{"date":"2021-02-19","current":51.861937,"twenty":50.11446,"median":51.553444,"eighty":52.089065,"marketCap":143367690309},{"date":"2021-02-26","current":58.788258,"twenty":50.29451,"median":51.620038,"eighty":52.588108,"marketCap":162157689039},{"date":"2021-03-05","current":56.545782,"twenty":50.420098,"median":51.774136,"eighty":54.987533,"marketCap":155581189484},{"date":"2021-03-12","current":57.260655,"twenty":50.670382,"median":51.806517,"eighty":56.523353,"marketCap":157272289370},{"date":"2021-03-19","current":58.922145,"twenty":50.72578,"median":51.861937,"eighty":57.761618,"marketCap":161781889065},{"date":"2021-03-26","current":45.655381,"twenty":50.29451,"median":51.834875,"eighty":57.761618,"marketCap":150248149840},{"date":"2021-04-01","current":44.402146,"twenty":49.232534,"median":51.785727,"eighty":57.72338,"marketCap":145740705344},{"date":"2021-04-09","current":46.245526,"twenty":48.491535,"median":51.774136,"eighty":57.445745,"marketCap":152126251713},{"date":"2021-04-16","current":45.843578,"twenty":47.071442,"median":51.620038,"eighty":56.905893,"marketCap":151375010963},{"date":"2021-04-23","current":47.941821,"twenty":46.674186,"median":51.544559,"eighty":56.595223,"marketCap":158699608268},{"date":"2021-04-30","current":47.292985,"twenty":46.892133,"median":51.338718,"eighty":56.478494,"marketCap":157197126770},{"date":"2021-05-07","current":44.686819,"twenty":46.674186,"median":50.949156,"eighty":55.644586,"marketCap":149496909090},{"date":"2021-05-14","current":47.693245,"twenty":46.358223,"median":50.678334,"eighty":54.98161,"marketCap":159450849017},{"date":"2021-05-21","current":49.252593,"twenty":46.446515,"median":50.318638,"eighty":54.739526,"marketCap":164709534262},{"date":"2021-05-28","current":34.796197,"twenty":46.015,"median":49.739468,"eighty":54.493388,"marketCap":161516761078},{"date":"2021-06-04","current":34.961943,"twenty":45.626349,"median":49.242564,"eighty":54.023478,"marketCap":161516761078},{"date":"2021-06-11","current":33.744804,"twenty":45.33083,"median":48.556215,"eighty":53.234644,"marketCap":155882455459},{"date":"2021-06-18","current":31.684335,"twenty":44.686491,"median":48.197481,"eighty":52.95221,"marketCap":145177274782},{"date":"2021-06-25","current":31.663274,"twenty":43.967373,"median":48.122902,"eighty":52.588108,"marketCap":144989464595},{"date":"2021-07-02","current":30.69154,"twenty":35.796618,"median":47.817533,"eighty":52.557854,"marketCap":140294209913},{"date":"2021-07-09","current":28.583686,"twenty":35.31878,"median":47.514473,"eighty":52.379013,"marketCap":130528080173},{"date":"2021-07-16","current":29.160074,"twenty":34.796197,"median":47.414412,"eighty":52.137563,"marketCap":133157422795},{"date":"2021-07-23","current":28.751555,"twenty":33.744804,"median":47.292985,"eighty":51.895074,"marketCap":131279320922},{"date":"2021-07-30","current":27.039046,"twenty":31.787963,"median":47.023101,"eighty":51.861937,"marketCap":123874830618},{"date":"2021-08-06","current":28.500789,"twenty":31.650912,"median":46.804358,"eighty":51.849781,"marketCap":130256261286},{"date":"2021-08-13","current":27.149641,"twenty":31.212428,"median":46.449805,"eighty":51.81997,"marketCap":124250208892},{"date":"2021-08-20","current":25.951827,"twenty":29.568647,"median":46.197194,"eighty":51.793063,"marketCap":118431845636},{"date":"2021-08-27","current":25.551317,"twenty":29.160074,"median":45.882896,"eighty":51.778391,"marketCap":117118021675},{"date":"2021-09-03","current":10.620748,"twenty":28.876855,"median":45.655381,"eighty":51.774136,"marketCap":128003991638},{"date":"2021-09-10","current":10.546903,"twenty":28.583686,"median":45.43354,"eighty":51.737204,"marketCap":127440924226},{"date":"2021-09-17","current":9.908289,"twenty":28.128178,"median":45.28035,"eighty":51.669892,"marketCap":119370291322},{"date":"2021-09-24","current":9.779132,"twenty":27.82689,"median":44.686819,"eighty":51.590126,"marketCap":117868778224},{"date":"2021-09-30","current":10.025874,"twenty":27.27478,"median":44.601887,"eighty":51.56014,"marketCap":121247182695},{"date":"2021-10-08","current":9.186602,"twenty":27.046772,"median":44.130413,"eighty":51.548113,"marketCap":111092433281},{"date":"2021-10-15","current":9.318231,"twenty":26.569923,"median":36.694857,"eighty":51.507128,"marketCap":112761505517},{"date":"2021-10-22","current":9.220183,"twenty":26.170808,"median":35.563772,"eighty":51.434346,"marketCap":112376076242},{"date":"2021-10-29","current":8.887419,"twenty":25.602517,"median":35.364793,"eighty":51.352853,"marketCap":108052495084},{"date":"2021-11-05","current":8.456886,"twenty":10.558373,"median":34.998178,"eighty":51.164241,"marketCap":102987534377},{"date":"2021-11-12","current":8.560231,"twenty":10.416496,"median":34.764786,"eighty":50.984786,"marketCap":104675854613},{"date":"2021-11-19","current":8.91034,"twenty":10.070918,"median":34.408066,"eighty":50.914517,"marketCap":108802859634},{"date":"2021-11-26","current":8.631049,"twenty":9.844574,"median":32.881851,"eighty":50.794169,"marketCap":105426219162},{"date":"2021-12-03","current":8.737756,"twenty":9.729778,"median":31.787963,"eighty":50.680984,"marketCap":106926948261},{"date":"2021-12-10","current":8.646346,"twenty":9.412104,"median":31.673805,"eighty":50.542589,"marketCap":105988992574},{"date":"2021-12-17","current":8.284795,"twenty":9.319774,"median":31.39672,"eighty":50.326681,"marketCap":101486805279},{"date":"2021-12-24","current":8.338086,"twenty":9.192112,"median":31.22719,"eighty":50.196443,"marketCap":102237169828},{"date":"2021-12-31","current":8.333922,"twenty":9.141505,"median":30.384431,"eighty":50.006669,"marketCap":102408380965},{"date":"2022-01-07","current":8.978555,"twenty":8.282213,"median":8.578854,"eighty":8.931855,"marketCap":109910826457},{"date":"2022-01-14","current":9.402408,"twenty":8.355848,"median":8.935267,"eighty":9.27511,"marketCap":115350099439},{"date":"2022-01-21","current":9.274157,"twenty":8.495499,"median":9.134096,"eighty":9.308362,"marketCap":114037171478},{"date":"2022-01-28","current":8.181531,"twenty":8.355848,"median":8.96544,"eighty":9.254892,"marketCap":100345208455},{"date":"2022-02-04","current":8.353845,"twenty":8.333922,"median":8.935267,"eighty":9.242048,"marketCap":102408380965},{"date":"2022-02-11","current":8.398082,"twenty":8.353845,"median":8.585644,"eighty":9.231359,"marketCap":103158625515},{"date":"2022-02-18","current":8.372232,"twenty":8.353845,"median":8.539109,"eighty":9.218737,"marketCap":103346186652},{"date":"2022-02-25","current":7.955221,"twenty":8.320426,"median":8.459805,"eighty":9.215937,"marketCap":98440722082},{"date":"2022-03-04","current":6.997914,"twenty":8.192451,"median":8.399622,"eighty":9.134096,"marketCap":86627835432},{"date":"2022-03-11","current":6.659587,"twenty":7.910139,"median":8.387341,"eighty":9.033931,"marketCap":82315194274},{"date":"2022-03-18","current":7.006091,"twenty":7.259352,"median":8.362252,"eighty":8.978555,"marketCap":86252823158},{"date":"2022-03-25","current":7.371317,"twenty":7.236339,"median":8.351954,"eighty":8.952325,"marketCap":90752970453},{"date":"2022-04-01","current":4.675869,"twenty":7.058972,"median":8.308293,"eighty":8.918209,"marketCap":84106186785},{"date":"2022-04-08","current":4.547747,"twenty":6.942633,"median":8.219605,"eighty":8.830117,"marketCap":81837075137},{"date":"2022-04-14","current":4.387704,"twenty":6.616876,"median":8.186991,"eighty":8.674624,"marketCap":78826492940},{"date":"2022-04-22","current":4.248774,"twenty":6.241316,"median":8.048348,"eighty":8.582928,"marketCap":74903847557},{"date":"2022-04-29","current":4.469038,"twenty":4.692503,"median":7.744517,"eighty":8.568318,"marketCap":77518944479},{"date":"2022-05-06","current":4.081901,"twenty":4.488006,"median":7.565869,"eighty":8.547152,"marketCap":70215607624},{"date":"2022-05-13","current":4.322075,"twenty":4.384485,"median":7.532014,"eighty":8.525703,"marketCap":73016762184},{"date":"2022-05-20","current":4.632904,"twenty":4.384485,"median":7.412742,"eighty":8.466335,"marketCap":79366045852},{"date":"2022-05-27","current":4.680568,"twenty":4.387704,"median":7.259352,"eighty":8.459805,"marketCap":80113020401},{"date":"2022-06-02","current":4.525356,"twenty":4.432565,"median":7.058972,"eighty":8.419371,"marketCap":77872096754},{"date":"2022-06-10","current":4.621539,"twenty":4.4352,"median":7.002002,"eighty":8.402782,"marketCap":78992558577},{"date":"2022-06-17","current":4.735988,"twenty":4.463986,"median":6.662821,"eighty":8.398698,"marketCap":80859994950},{"date":"2022-06-24","current":5.142082,"twenty":4.471352,"median":6.514843,"eighty":8.397313,"marketCap":88142996805},{"date":"2022-06-30","current":5.423776,"twenty":4.472615,"median":6.245656,"eighty":8.391253,"marketCap":92811587738},{"date":"2022-07-08","current":5.73435,"twenty":4.494949,"median":5.753227,"eighty":8.378276,"marketCap":98227153219},{"date":"2022-07-15","current":5.413863,"twenty":4.510715,"median":5.74317,"eighty":8.371172,"marketCap":91877869551},{"date":"2022-07-22","current":5.179385,"twenty":4.519814,"median":5.724312,"eighty":8.360609,"marketCap":87956253168},{"date":"2022-07-29","current":4.986361,"twenty":4.532767,"median":5.592688,"eighty":8.353922,"marketCap":84781611334},{"date":"2022-08-05","current":4.966061,"twenty":4.543731,"median":5.423776,"eighty":8.35271,"marketCap":84221380422},{"date":"2022-08-12","current":4.728381,"twenty":4.557367,"median":5.285894,"eighty":8.341135,"marketCap":80299764039},{"date":"2022-08-19","current":4.642899,"twenty":4.56463,"median":5.258084,"eighty":8.325824,"marketCap":78058840391},{"date":"2022-08-26","current":8.493761,"twenty":4.56647,"median":5.277824,"eighty":8.341135,"marketCap":78058840391},{"date":"2022-09-02","current":8.238862,"twenty":4.578556,"median":5.413863,"eighty":8.355149,"marketCap":75444429469},{"date":"2022-09-09","current":8.208746,"twenty":4.591042,"median":5.480211,"eighty":8.353922,"marketCap":74882486287},{"date":"2022-09-16","current":8.11962,"twenty":4.598745,"median":5.696236,"eighty":8.353089,"marketCap":73385034348},{"date":"2022-09-23","current":7.794047,"twenty":4.606594,"median":5.727415,"eighty":8.344741,"marketCap":69090235901},{"date":"2022-09-30","current":7.678478,"twenty":4.613732,"median":5.752609,"eighty":8.328524,"marketCap":68195810112},{"date":"2022-10-07","current":7.78297,"twenty":4.623812,"median":5.823839,"eighty":8.317285,"marketCap":69119872580},{"date":"2022-10-14","current":8.22397,"twenty":4.634903,"median":6.267354,"eighty":8.303007,"marketCap":72261684970},{"date":"2022-10-21","current":8.894846,"twenty":4.643031,"median":6.606198,"eighty":8.353467,"marketCap":77621247282},{"date":"2022-10-28","current":8.400958,"twenty":4.643734,"median":6.721508,"eighty":8.371879,"marketCap":73185747437},{"date":"2022-11-04","current":8.90828,"twenty":4.646216,"median":7.016023,"eighty":8.396002,"marketCap":78360497256},{"date":"2022-11-11","current":9.100313,"twenty":4.655414,"median":7.236339,"eighty":8.407643,"marketCap":80763059672},{"date":"2022-11-18","current":9.403245,"twenty":4.664392,"median":7.335813,"eighty":8.46442,"marketCap":83165622088},{"date":"2022-11-25","current":8.930799,"twenty":4.668952,"median":7.531332,"eighty":8.525171,"marketCap":78360497256},{"date":"2022-12-02","current":9.296925,"twenty":4.676809,"median":7.555053,"eighty":8.584286,"marketCap":82980809594},{"date":"2022-12-09","current":9.313941,"twenty":4.687945,"median":7.567538,"eighty":8.707566,"marketCap":83904872062},{"date":"2022-12-16","current":9.397407,"twenty":4.719639,"median":7.647562,"eighty":8.81303,"marketCap":84459309543},{"date":"2022-12-23","current":9.086129,"twenty":4.729099,"median":7.698595,"eighty":8.889427,"marketCap":81687122140},{"date":"2022-12-30","current":9.281716,"twenty":4.731254,"median":7.710864,"eighty":8.915011,"marketCap":84459309543},{"date":"2023-01-06","current":9.328055,"twenty":4.734382,"median":7.731498,"eighty":8.96145,"marketCap":85752996997},{"date":"2023-01-13","current":9.843426,"twenty":4.737165,"median":7.764775,"eighty":9.024693,"marketCap":92221434271},{"date":"2023-01-20","current":9.630169,"twenty":4.739933,"median":7.808834,"eighty":9.11954,"marketCap":89449246868},{"date":"2023-01-27","current":9.76745,"twenty":4.741255,"median":7.828,"eighty":9.134096,"marketCap":90742934323},{"date":"2023-02-03","current":9.242159,"twenty":4.749977,"median":7.910139,"eighty":9.14912,"marketCap":86307434478},{"date":"2023-02-10","current":8.939647,"twenty":4.760926,"median":7.994821,"eighty":9.145292,"marketCap":82980809594},{"date":"2023-02-17","current":8.502405,"twenty":4.779418,"median":8.042416,"eighty":9.134096,"marketCap":78175684763},{"date":"2023-02-24","current":8.382439,"twenty":4.784909,"median":8.105078,"eighty":9.13158,"marketCap":76130387334},{"date":"2023-03-03","current":8.590767,"twenty":4.786195,"median":8.138516,"eighty":9.111513,"marketCap":78525547250},{"date":"2023-03-10","current":8.613919,"twenty":8.572182,"median":8.603737,"eighty":8.631438,"marketCap":78156015263},{"date":"2023-03-17","current":8.854074,"twenty":8.686159,"median":14.627146,"eighty":50.137268,"marketCap":81112271159},{"date":"2023-03-24","current":8.653874,"twenty":8.680699,"median":14.555372,"eighty":50.059787,"marketCap":80188441192},{"date":"2023-03-31","current":8.841045,"twenty":8.682095,"median":14.465882,"eighty":50.052946,"marketCap":81297037153},{"date":"2023-04-06","current":26.385992,"twenty":8.683492,"median":14.468662,"eighty":50.046105,"marketCap":76623190314},{"date":"2023-04-14","current":29.091238,"twenty":8.680699,"median":14.463101,"eighty":49.815888,"marketCap":84562460636},{"date":"2023-04-21","current":28.343601,"twenty":8.680699,"median":14.463101,"eighty":49.757313,"marketCap":82346850314},{"date":"2023-04-28","current":27.787899,"twenty":8.680699,"median":14.463101,"eighty":49.691641,"marketCap":80131239992},{"date":"2023-05-05","current":27.186497,"twenty":8.680699,"median":14.463101,"eighty":49.389192,"marketCap":78525547250},{"date":"2023-05-12","current":26.022356,"twenty":8.680699,"median":14.463101,"eighty":49.1783,"marketCap":74645461386},{"date":"2023-05-19","current":25.609528,"twenty":8.680699,"median":14.463101,"eighty":48.945058,"marketCap":72428269463},{"date":"2023-05-25","current":25.452944,"twenty":8.682095,"median":14.465882,"eighty":48.625163,"marketCap":71689205489},{"date":"2023-06-02","current":24.881313,"twenty":8.680699,"median":14.463101,"eighty":48.313875,"marketCap":69841545554},{"date":"2023-06-09","current":25.44461,"twenty":8.680699,"median":14.463101,"eighty":48.13438,"marketCap":71319673502},{"date":"2023-06-16","current":25.567055,"twenty":8.680699,"median":14.463101,"eighty":47.936748,"marketCap":71319673502},{"date":"2023-06-23","current":22.156893,"twenty":8.680699,"median":14.463101,"eighty":47.800493,"marketCap":61469866445},{"date":"2023-06-30","current":22.891344,"twenty":8.680699,"median":14.463101,"eighty":47.612323,"marketCap":62932979993},{"date":"2023-07-07","current":23.003349,"twenty":8.682095,"median":14.465882,"eighty":47.475199,"marketCap":63117534187},{"date":"2023-07-14","current":23.348328,"twenty":8.682095,"median":14.465882,"eighty":47.339122,"marketCap":64963076122},{"date":"2023-07-21","current":23.124147,"twenty":8.682095,"median":14.465882,"eighty":47.120587,"marketCap":64040305154},{"date":"2023-07-28","current":23.882752,"twenty":8.682095,"median":14.465882,"eighty":46.941508,"marketCap":66070401283},{"date":"2023-08-04","current":22.5111,"twenty":8.682095,"median":14.465882,"eighty":46.556098,"marketCap":62379317413},{"date":"2023-08-11","current":21.031429,"twenty":8.682095,"median":14.465882,"eighty":46.490275,"marketCap":57950016768},{"date":"2023-08-18","current":20.109761,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55013725665},{"date":"2023-08-25","current":27.35707,"twenty":8.682095,"median":14.465882,"eighty":46.446515,"marketCap":55381710452},{"date":"2023-09-01","current":26.972418,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54829733271},{"date":"2023-09-08","current":26.744198,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":53725778910},{"date":"2023-09-15","current":26.901969,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54461748484},{"date":"2023-09-22","current":26.83754,"twenty":8.682095,"median":14.465882,"eighty":46.385567,"marketCap":54093763697},{"date":"2023-09-29","current":25.789185,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-06","current":25.16334,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":50781900614},{"date":"2023-10-13","current":25.840139,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52069847368},{"date":"2023-10-20","current":24.416834,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":49125969072},{"date":"2023-10-27","current":26.714516,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53725778910},{"date":"2023-11-03","current":30.567338,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":61637451832},{"date":"2023-11-10","current":31.39511,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63293383374},{"date":"2023-11-17","current":34.642006,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":70469086721},{"date":"2023-11-24","current":33.820877,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":69365132360},{"date":"2023-12-01","current":33.323855,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":68629162786},{"date":"2023-12-08","current":30.229794,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":62005436619},{"date":"2023-12-15","current":30.948108,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2023-12-22","current":28.291375,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":58325588749},{"date":"2023-12-29","current":30.804548,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":63845360554},{"date":"2024-01-05","current":29.592871,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":60901482258},{"date":"2024-01-12","current":28.772914,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":59245550716},{"date":"2024-01-19","current":26.217575,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53909771304},{"date":"2024-01-26","current":25.960692,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":53173801730},{"date":"2024-02-02","current":25.634057,"twenty":8.683492,"median":14.468662,"eighty":46.379948,"marketCap":52437832156},{"date":"2024-02-09","current":26.045455,"twenty":8.684903,"median":14.482873,"eighty":46.363102,"marketCap":53541786517},{"date":"2024-02-16","current":28.187439,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57957603961},{"date":"2024-02-23","current":28.246863,"twenty":8.684889,"median":14.468775,"eighty":46.374329,"marketCap":57773611568},{"date":"2024-03-01","current":27.959549,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":57221634387},{"date":"2024-03-08","current":26.060017,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":53357794123},{"date":"2024-03-15","current":29.321008,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":59981520290},{"date":"2024-03-22","current":27.457347,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":56117680026},{"date":"2024-03-28","current":27.274509,"twenty":8.684896,"median":14.468889,"eighty":46.368715,"marketCap":55565702846},{"date":"2024-04-05","current":20.502088,"twenty":8.68491,"median":14.545212,"eighty":46.385567,"marketCap":51738890207},{"date":"2024-04-12","current":19.836504,"twenty":8.684917,"median":14.622337,"eighty":46.379948,"marketCap":50087649030},{"date":"2024-04-19","current":17.00797,"twenty":8.684917,"median":14.824165,"eighty":46.379948,"marketCap":42908870597},{"date":"2024-04-26","current":20.158221,"twenty":8.685111,"median":15.006965,"eighty":46.368715,"marketCap":50793833997},{"date":"2024-05-03","current":20.900402,"twenty":8.685111,"median":17.666939,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-10","current":22.594528,"twenty":8.68601,"median":19.495478,"eighty":46.368715,"marketCap":57028456221},{"date":"2024-05-17","current":22.482225,"twenty":8.68601,"median":19.836504,"eighty":46.368715,"marketCap":56661713737},{"date":"2024-05-24","current":20.929348,"twenty":8.68601,"median":20.158221,"eighty":46.368715,"marketCap":52627546416},{"date":"2024-05-31","current":20.689517,"twenty":8.68601,"median":20.438856,"eighty":46.368715,"marketCap":52077432691},{"date":"2024-06-07","current":20.788148,"twenty":8.707461,"median":20.694975,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-06-14","current":20.150143,"twenty":8.757175,"median":20.694975,"eighty":46.368715,"marketCap":50610462756},{"date":"2024-06-21","current":19.02184,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":47676522886},{"date":"2024-06-28","current":19.542074,"twenty":8.763371,"median":20.705001,"eighty":46.368715,"marketCap":48960121579},{"date":"2024-07-05","current":20.717633,"twenty":8.763371,"median":20.708507,"eighty":46.368715,"marketCap":51894061449},{"date":"2024-07-12","current":21.125844,"twenty":8.763371,"median":20.717171,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-07-19","current":20.833056,"twenty":8.763371,"median":20.76172,"eighty":46.368715,"marketCap":52260803932},{"date":"2024-07-26","current":20.391805,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-02","current":20.403694,"twenty":8.763371,"median":20.774673,"eighty":46.368715,"marketCap":51343947723},{"date":"2024-08-09","current":20.920099,"twenty":8.763371,"median":20.788148,"eighty":46.368715,"marketCap":52994288900},{"date":"2024-08-16","current":13.474849,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":59895993625},{"date":"2024-08-23","current":12.806368,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57165173247},{"date":"2024-08-30","current":13.085579,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58803665474},{"date":"2024-09-06","current":12.836322,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":57711337322},{"date":"2024-09-13","current":13.073008,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":58621610782},{"date":"2024-09-20","current":13.560082,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":61170376468},{"date":"2024-09-27","current":14.842966,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":67360235991},{"date":"2024-10-04","current":16.724157,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":75552697126},{"date":"2024-10-10","current":15.372928,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":68998728218},{"date":"2024-10-18","current":15.412732,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":68816673526},{"date":"2024-10-25","current":14.435061,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":64447360921},{"date":"2024-11-01","current":14.669834,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":65539689073},{"date":"2024-11-08","current":14.122653,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":62808868695},{"date":"2024-11-15","current":13.694576,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60260103008},{"date":"2024-11-22","current":13.659673,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-11-29","current":13.461736,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59167774857},{"date":"2024-12-06","current":13.618076,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":59713938933},{"date":"2024-12-13","current":13.728207,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":60078048317},{"date":"2024-12-20","current":13.413238,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58439556090},{"date":"2024-12-27","current":13.507288,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":58803665474},{"date":"2025-01-03","current":12.783861,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":55708735712},{"date":"2025-01-10","current":11.99376,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52067641874},{"date":"2025-01-17","current":12.179201,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52915350334},{"date":"2025-01-24","current":11.936992,"twenty":8.759333,"median":20.864379,"eighty":46.374329,"marketCap":52187991566},{"date":"2025-01-28","current":11.667884,"twenty":8.763371,"median":20.833056,"eighty":46.368715,"marketCap":51278793107},{"date":"2025-02-07","current":12.358438,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":54006388485},{"date":"2025-02-14","current":13.472496,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58734220474},{"date":"2025-02-21","current":13.855323,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":60734457084},{"date":"2025-02-28","current":13.401695,"twenty":8.758794,"median":20.895702,"eighty":46.379948,"marketCap":58552380782},{"date":"2025-03-07","current":13.845547,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":60734457084},{"date":"2025-03-14","current":14.627846,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64189411230},{"date":"2025-03-21","current":17.171853,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":64449578833},{"date":"2025-03-28","current":17.828023,"twenty":8.758254,"median":20.898052,"eighty":46.385567,"marketCap":66776924735},{"date":"2025-04-03","current":18.607188,"twenty":8.758254,"median":20.78141,"eighty":46.385567,"marketCap":69557715461},{"date":"2025-04-11","current":17.2596,"twenty":8.758254,"median":20.717402,"eighty":46.357488,"marketCap":64091525617},{"date":"2025-04-17","current":17.642281,"twenty":8.758794,"median":20.705001,"eighty":46.234928,"marketCap":65669735088},{"date":"2025-04-25","current":18.971902,"twenty":8.757715,"median":20.631385,"eighty":45.993268,"marketCap":70679960108},{"date":"2025-05-02","current":19.027519,"twenty":8.758254,"median":20.543459,"eighty":45.790243,"marketCap":71037833324},{"date":"2025-05-09","current":18.60931,"twenty":8.757715,"median":20.427733,"eighty":45.434847,"marketCap":69964213677},{"date":"2025-05-16","current":19.119426,"twenty":8.757715,"median":20.391805,"eighty":44.686655,"marketCap":72469326187},{"date":"2025-05-23","current":19.674285,"twenty":8.757715,"median":20.317327,"eighty":41.07031,"marketCap":74795502089},{"date":"2025-05-30","current":20.853432,"twenty":8.757715,"median":20.194397,"eighty":35.483307,"marketCap":79626790502},{"date":"2025-06-06","current":21.257091,"twenty":8.757715,"median":20.194397,"eighty":34.895645,"marketCap":81375206580},{"date":"2025-06-13","current":25.825329,"twenty":8.757715,"median":20.194397,"eighty":34.568065,"marketCap":98902174152},{"date":"2025-06-20","current":23.349274,"twenty":8.757715,"median":20.194397,"eighty":34.239735,"marketCap":89244457327},{"date":"2025-06-27","current":24.730575,"twenty":8.758254,"median":20.194879,"eighty":33.775233,"marketCap":94788702171}],"updateTime":1751107765579}}}